Press releases
- Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes
- Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution
- Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health
- Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health
- DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results
- DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH
- New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications
- DARIOHEALTH TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTHCARE CONFERENCE
- Dario acquires Twill creating one of the most comprehensive digital health platform across the most prevalent chronic conditions
More ▼
Key statistics
On Friday, DarioHealth Corp (LS1P:BER) closed at 0.99, 40.43% above the 52 week low of 0.705 set on Nov 02, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.99 |
---|---|
High | 0.99 |
Low | 0.99 |
Bid | 1.31 |
Offer | 1.46 |
Previous close | 0.99 |
Average volume | 920.00 |
---|---|
Shares outstanding | 29.44m |
Free float | 25.08m |
P/E (TTM) | -- |
Market cap | 43.57m USD |
EPS (TTM) | -2.24 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 07:33 BST.
More ▼